Healthcare - Press Releases

CHENGDU, China, 10 de febrero de 2025 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) ha anunciado hoy que la Administracin Nacional de Productos Mdicos (NMPA) de China ha aprobado recientemente la solicitud de nuevo frmaco complementario (sNDA) de Stapokibart (anticuerpo monoclonal anti-IL-4R, nombre comercial: Kangyueda (), para el tratamiento de la rinitis alrgica estacional.

SO PAULO, Feb. 8, 2025 /PRNewswire/ -- Chef&Nutriwasborn out of the need to encourage healthier living. Focused on the ingestion of nutritionally complete, sustainable and functional foods, based in Bahia, the company is expanding its operations to the Southeast, Midwest and South, in this year of 2025, with numerous innovations, always using the best and most modern has emerged to demystify the idea that healthy food is synonymous with sacrifice, proposing that each meal can be a true celebration of taste and constant well-being.

Global Financial Market Review (GFM) is a dedicated online news aggregation portal specializing in financial market news and industry updates. It combines original editorials with curated content from global news providers, reaching over 14 million readers annually. With a focus on reliability and depth, GFM has positioned itself as a trusted source in the financial sector, boasting a strong social media presence with over 180,000 Twitter followers.

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year

VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStopfor the treatment of acid reflux, a treatment field with 1 billion sufferers, announcesonboarding of the 12thCenter of Excellence in Spain, the La Paz University Hospital in Madrid, one of the most prestigious and world-leading hospitals.

Surgeons in Sweden, Finland and Denmark can now expect enhanced support, seamless service, and expanded access to POLYTECH's cutting-edge breast implant portfolio

BERLIN, Feb. 6, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 225Ac-SSO110 (satoreotide) for the treatment of patients with Small Cell Lung Cancer (SCLC).

LONDON, Feb. 6, 2025 /PRNewswire/ -- Accord Healthcare Limited (Accord) announced today that the anti-PD-1 mAb, serplulimab, marketed as Hetronifly in Europe, has been officially approved by the European Commission (EC) for use in combination with carboplatin and etoposide as a first-line treatment for ES-SCLC.

- Over $137m of aid distributed to 106 countries from Dubai Humanitarian aid hub used by international organisations including UNICEF, IFRC, WHO and WFP

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global blood marketsize is estimated to grow by USD 2.60 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.94% during the forecast period. Rising number of hospitals and blood banksis driving market growth,with a trend towardsrising awareness about blood donation. However,low availability of blood storage/transfusion facilities in rural areas poses a challenge. Key market players include Abbott Laboratories, AXO Science, BAG Health Care GmbH, Becton Dickinson and Co., Bio Rad Laboratories Inc., Cardinal Health Inc., CSL Ltd., Danaher Corp., DIAGAST SAS, F. Hoffmann La Roche Ltd., Grifols SA, Haemonetics Corp., Medtronic Plc, Merck KGaA, Mesa Laboratories Inc., Nipro Corp., QuidelOrtho Corp., Rapid Labs Ltd., Terumo Corp., Thermo Fisher Scientific Inc., and Werfenlife SA.

PALO ALTO, Calif., Feb. 6, 2025 /PRNewswire/ -- Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a pioneering developer of connected add-on devices for drug delivery devices, today announced a strategic partnership to develop and deploy digital companion apps with the adaptive DOSE platform hardware add-on technology for injectable therapies. This collaboration aims to revolutionize the management of injectable medications by providing comprehensive connectivity and data capture solutions for dosing, storage, and injection techniques.

LONDON, Feb. 6, 2025 /PRNewswire/ --Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.

LONDON, 6. Februar 2025 /PRNewswire/ -- Inizio, ein Vermarktungspartner fr Gesundheits- und Biowissenschaftsunternehmen, hat heute die Ernennung von Colin Stanley zum Chief Commercial Officer (CCO), Remco op den Kelder zum Prsidenten von Inizio Advisory und Jim Sage zum Prsidenten von Inizio Engage bekannt gegeben.

LONDRES, 6 fvrier 2025 /PRNewswire/ -- Inizio, un partenaire de commercialisation pour les entreprises du secteur de la sant et des sciences de la vie, a annonc aujourd'hui la nomination de Colin Stanley au poste de Chief Commercial Officer (CCO), de Remco op den Kelder au poste de prsident d'Inizio Advisory et de Jim Sage au poste de prsident d'Inizio Engage.

Free Our Sports is a campaign of Alcohol Justice focused on ending the toxic relationship between alcohol advertising and sports. Alcohol Justice logo. (PRNewsFoto/Alcohol Justice)

Free Our Sports (Liberen nuestros deportes) es una campaa de Alcohol Justice con el objetivo de ponerle fin a la relacin txica entre las publicidades de bebidas alcohlicas y los deportes. Alcohol Justice logo. (PRNewsFoto/Alcohol Justice)

NEW YORK, 6 fvrier 2025 /PRNewswire/ --Stax LLC, une socit de conseil en stratgie mondiale spcialise dans la due diligence commerciale, la cration de valeur et la planification de sortie pour les socits de capital-investissement, les socits finances par le capital-investissement, les fonds spculatifs et les banques d'investissement, a le plaisir d'annoncer la nomination d'Adam Thorpe au poste de directeur gnral dans son bureau de Londres. ce titre, Adam dirigera le secteur vertical des soins de sant de l'entreprise dans la rgion EMEA.

NEW YORK, Feb. 6, 2025 /PRNewswire/ --Stax LLC, a global strategy consulting firm specializing in commercial due diligence, value creation, and exit planning for private equity firms, PE-backed companies, hedge funds, and investment banks, is pleased to announce the appointment of Adam Thorpe as a Managing Director in its London office. In this role, Adam will lead the firm's EMEA healthcare vertical.

NEW YORK, 6 februari 2025 /PRNewswire/ --Stax LLC, een wereldwijd strategieadviesbureau gespecialiseerd in commercieel due diligence-onderzoek, waardecreatie en exitplanning voor private equity-ondernemingen, PE-bedrijven, hedgefondsen en investeringsbanken, kondigt met genoegen aan dat het Adam Thorpe heeft benoemd tot Managing Director voor het kantoor in Londen. In deze rol zal Adam leiding geven aan de gezondheidszorgvertical in EMEA.

NEW YORK, 6. Februar 2025 /PRNewswire/ -- Stax LLC, ein globales Strategieberatungsunternehmen, das sich auf kommerzielle Due-Diligence-Prfungen, Wertschpfung und Exit-Planung fr Private-Equity-Firmen, PE-untersttzte Unternehmen, Hedgefonds und Investmentbanken spezialisiert hat, freut sich, die Ernennung von Adam Thorpe zum Managing Director in seinem Londoner Bro bekannt zu geben. In dieser Funktion wird Adam den Bereich EMEA Healthcare Vertical leiten.

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global analytical standards marketsize is estimated to grow by USD 657.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Rapid growth in life science industryis driving market growth,with a trend towardsincreasing adoption of custom standards. However,limited shelf life of analytical standards poses a challenge. Key market players include AccuStandard Inc., Agilent Technologies, Inc., Cayman Chemical, Chiron AS, GFS Chemicals, Inc., LGC Limited, Mallinckrodt, Merck KGaA, PerkinElmer, Inc., Restek Corporation, Ricca Chemical Company, SPEX CertiPrep, The United States Pharmacopeial Convention, Thermo Fisher Scientific Inc., Waters Corporation

COPENHAGEN, Denmark and LONDON, Feb. 5, 2025 /PRNewswire/ -- Liva Healthcare ("Liva" or "the Company"), a digital health technology platform with human-led therapeutic intervention programmes that deliver best-in-class outcomes for lifestyle-related chronic diseases, today announces that it has acquired UK-based Discover Momenta, including subsidiary Momenta Newcastle, for an undisclosed sum. The acquisition of Momenta is part of Liva's growth strategy as it emerges as a major international provider of evidence-based therapeutic lifestyle interventions.

HELSINKI, Feb. 5, 2025 /PRNewswire/ -- UPM-Kymmene CorporationStock Exchange Release (Other information disclosed according to the rules of the Exchange) 5 February 2025 at 09:50 EET

NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ --Sony Group Corporation (Sony) and Nature are proud to announce the inaugural recipients of the Sony Women in Technology Award with Nature, honoring outstanding early to mid-career women researchers who are spearheading breakthroughs for the betterment of society and the planet in the field of technology (science, engineering, and mathematics). The award grants each winner a prize of $250,000 to support and accelerate their technological research.